David R. Thomas, M.D., and John E. Morley, M.D.
During the last three years, Dr. Thomas has received grant/research support from Nestle. During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Pharmacia, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia, GlaxoSmithKline, Aventis, Searle, Roche, Bristol-Myers Squibb, Novartis, Pratt, B.Braun McGaw, Pfizer and Solvay.
This Cyberounds® is published simultaneously in the Supplement to the July 2002 issue of Annals of Long-Term Care, in cooperation with the Council for Nutritional Clinical Strategies in Long-Term Care, which received an unrestricted educational grant from Solvay Pharmaceuticals, Inc.
Estimated time to complete:
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®
, you should be able to:
- Discuss the high prevalence of malnutrition in older persons
- List the effects and side effects of different orexigenics
- Discuss the rationale for treating malnutrition in older persons.